Molecular Imaging: Page 124

NorthStar licenses fibrin-targeted cardiac SPECT agent
By AuntMinnie.com staff writers
NorthStar Medical Radioisotopes parent NorthStar Medical Technologies has signed an agreement with imaging agent developer Capella Imaging to exclusively license an investigational cardiac SPECT radiopharmaceutical.
March 2, 2020
2017 02 10 15 45 57 410 Heart 400
AuntMinnie Molecular Imaging Insider
By Wayne Forrest
March 2, 2020
Curium acquires Zevacor Molecular
By AuntMinnie.com staff writers
Nuclear medicine firm Curium Pharma has acquired radiopharmaceutical developer Zevacor Molecular in a deal aimed at strengthening its PET portfolio.
March 2, 2020
2019 12 19 00 53 5252 Hands Shaking Deal 400
PET shows connection with widowhood, Alzheimer's decline
By Kate Madden Yee
Men and women who had been widowed and who had elevated beta-amyloid levels on PET scans were also more likely to have accelerated cognitive decline associated with Alzheimer's disease, according to a study published online February 26 in JAMA Network Open.
February 25, 2020
2020 02 26 21 58 9112 Alzheimers Tau Tangles 400
Flortaucipir-PET, blood samples link brain injuries to CTE
By Wayne Forrest
Flortaucipir-PET and blood tests have correlated two key biomarkers of chronic traumatic encephalopathy (CTE) in military personnel who experienced traumatic brain injuries from blasts, according to a study published online on February 25 in Molecular Psychiatry.
February 25, 2020
2018 07 24 00 33 7964 Brain 400
Lantheus reports revenue increases for Q4, 2019
By AuntMinnie.com staff writers
Lantheus Medical Imaging parent Lantheus Holdings has reported growth in 2019 fourth-quarter and full-year revenues, although its net income declined.
February 24, 2020
2019 10 31 18 11 2421 Graph Financial Results Tablet 400
Precision Molecular wins investment from ADDF
By AuntMinnie.com staff writers
Imaging biomarker and theranostics technology developer Precision Molecular said it has received an investment from the Alzheimer's Drug Discovery Foundation (ADDF) to support the development of imaging agents for brain inflammation.
February 19, 2020
2017 04 14 16 09 55 745 Amyloid Plaque Alzheimer 400
Jubilant claims win in patent dispute with Bracco
By AuntMinnie.com staff writers
Jubilant DraxImage said that it has received favorable rulings from the U.S. Patent and Trademark Office relating to its ongoing dispute with Bracco Diagnostics.
February 18, 2020
2016 12 21 15 58 26 460 Scales Of Justice 400
NorthStar gets FDA nod for more Mo-99 filling lines
By AuntMinnie.com staff writers
NorthStar Medical Radioisotopes has garnered U.S. Food and Drug Administration (FDA) approval for additional molybdenum-99 (Mo-99) filling lines at its Columbia, MO, facility, paving the way for increased production of the isotope, which is a precursor to technetium-99m.
February 18, 2020
2018 04 24 20 24 4264 Isotope 400
Hermes lands FDA clearance for Affinity
By AuntMinnie.com staff writers
Swedish nuclear medicine software developer Hermes Medical Solutions has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Affinity viewing and analysis software for molecular imaging and nuclear medicine exams.
February 17, 2020
2019 01 05 00 38 5275 Molecular Imaging 400
Amyloid PET results prompt adults to rethink their future
By Wayne Forrest
When PET scans reveal elevated amyloid levels in cognitively normal older adults, the prospect of possibly progressing to Alzheimer's disease prompts many of them to reconsider their future priorities.
February 17, 2020
2017 04 14 16 09 55 745 Amyloid Plaque Alzheimer 400
Isotopia, Eckert & Ziegler partner
By AuntMinnie.com staff writers
Isotopia Molecular Imaging has partnered with isotope technology firm Eckert & Ziegler for the development of its PSMA-11 kit for prostate cancer imaging.
February 17, 2020
2019 11 11 22 17 5854 Arrows Join Partner 400
Previous Page
Page 124 of 614
Next Page